Literature DB >> 4572012

5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines.

M B Bowers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4572012     DOI: 10.1007/bf00422751

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  10 in total

Review 1.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

2.  Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.

Authors:  T Kolakowska; D H Wiles; M G Gelder; A S McNeilly
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

3.  Endogenous ligands of a putative LSD-serotonin receptor in the cerebrospinal fluid: higher level of LSD-displacing factors (LDF) in unmedicated psychotic patients.

Authors:  E Mehl; E Rüther; J Redemann
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

4.  Probenecid-induced increase of 5-hydroxytryptamine synthesis in rat brain, as measured by formation of 5-hydroxytryptophan.

Authors:  M van Wijk; J B Sebens; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

5.  Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.

Authors:  M B Bowers; D Moore; D Tarsy
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

6.  Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.

Authors:  J Rotrosen; B M Angrist; S Gershon; E J Sachar; F S Halpern
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

7.  Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.

Authors:  J K Yao; G G Dougherty; R D Reddy; M S Keshavan; D M Montrose; W R Matson; S Rozen; R R Krishnan; J McEvoy; R Kaddurah-Daouk
Journal:  Mol Psychiatry       Date:  2009-04-28       Impact factor: 15.992

8.  Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space.

Authors:  F W Van der Poel; H M Van Praag; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

Review 9.  Clinical investigation of monoamine neurotransmitter interactions.

Authors:  J K Hsiao; W Z Potter; H Agren; R R Owen; D Pickar
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

Authors:  W Z Potter
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.